Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

Very sick patients who get a bone marrow transplant at Medical University of South Carolina survive at a much higher rate ...

Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...

NEW YORK - IN8bio, Inc. (Nasdaq: INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies with a current market capitalization of $23.42 million, has announced encouraging Phase ...

A new study from Université de Montréal and CHU Sainte-Justine Azrieli Research Centre, published in the International ...

Improved diagnostics and treatments mean that the survival rate for children with cancer continues to increase, the ...

More children are surviving cancer because of improved diagnostic methods and targeted treatment, figures from Dutch cancer ...

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...

The five-year survival rate of children under 15 diagnosed with leukemia, which is a common form of cancer in childhood, stood at 88 percent. Children with a brain tumor showed a lower survival ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...